HPMA copolymer–phospholipase C and dextrin–phospholipase A2 as model triggers for polymer enzyme liposome therapy (PELT)

References

• Soloman R, Gabizon AA. Clinical pharmacology of liposomal anthracyclines: focus on pegylated liposomal doxorubicin. Clin Lymphoma Myeloma. 2008;8:21–32.
   PubMedGoogle Scholar
• Lorusso V, Manzione L, Silvestris N. Role of liposomal anthracyclines in breast cancer. Ann Oncol. 2007;18(Suppl 6):vi70–vi73.
   PubMed Web of Science ®Google Scholar
• Maeda H, Wu J, Sawa T, et al. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release. 2000;65:271–284.
   PubMed Web of Science ®Google Scholar
• Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov. 2005;4:145–160.
   PubMed Web of Science ®Google Scholar
• Yokomichi N, Nagasawa T, Coler-Reilly A, et al. Pathogenesis of hand–foot syndrome induced by PEG-modified liposomal Doxorubicin. Hum Cell. 2013;26:8–18.
   PubMed Web of Science ®Google Scholar
• Andresen TL, Jensen SS, Jorgensen K. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res. 2005;44:68–97.
   PubMed Web of Science ®Google Scholar
• Duncan R, Gac-Breton S, Keane R, et al. Polymer-drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to clinic. J Control Release. 2001;74:135–146.
   PubMed Web of Science ®Google Scholar
• Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies. Clin Pharmacokinet. 2003;42:419–436.
   PubMed Web of Science ®Google Scholar
• Bellott R, Auvrignon A, Leblanc T, et al. Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I–II study in children with relapsed acute lymphoblastic leukaemia. Cancer Chemother Pharmacol. 2001;47:15–21.
   PubMed Web of Science ®Google Scholar
• Vicent MJ, Ringsdorf H, Duncan R. Polymer therapeutics: clinical applications and challenges for development. Adv Drug Deliv Rev. 2009;61:1117–1120.
   PubMed Web of Science ®Google Scholar
• Mistry CD, Gokal R. The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview. Peritoneal Dial Int. 1994;14(Suppl 3):S158–S161.
   PubMedGoogle Scholar
• Chytry V, Vrana A, Kopecek J. Synthesis and activity of a polymer which contains insulin covalently bound on a copolymer of N-(2-hydroxypropyl)methacrylamide and N-methacryloyldiglycyl p-nitrophenyl ester. Makromol Chem. 1978;179:329–336.
   Web of Science ®Google Scholar
• Sure V, Etrych T, Ulbrich K, et al. Synthesis and properties of poly[N-(2-hydroxypropyl) methacrylamide] conjugates of superoxide dismutase. J Bioact Compat Polym. 2002;17:105–122.
   Web of Science ®Google Scholar
• Satchi R, Connors TA, Duncan R. PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer–cathepsin B and PK1 as a model combination. Br J Cancer. 2001;85:1070–1076.
   PubMed Web of Science ®Google Scholar
• Satchi-Fainaro R, Hailu H, Davies JW, et al. PDEPT: polymer-directed enzyme prodrug therapy. 2. HPMA copolymer–beta-lactamase and HPMA copolymer-C-Dox as a model combination. Bioconjug Chem. 2003;14:797–804.
   PubMed Web of Science ®Google Scholar
• Satchi-Fainaro R, Wrasidlo W, Lode HN, et al. Synthesis and characterization of a catalytic antibody-HPMA copolymer–conjugate as a tool for tumor selective prodrug activation. Bioorg Med Chem. 2002;10:3023–3029.
   PubMed Web of Science ®Google Scholar
• Duncan R, Gilbert HRP, Carbajo RJ, et al. Polymer masked-unmasked protein therapy (PUMPT) 1. Bioresponsive dextrin–trypsin and -MSH conjugates designed for α-amylase activation. Biomacromolecules. 2008;9:1146–1154.
   PubMed Web of Science ®Google Scholar
• Ferguson EL, Duncan R. Dextrin–phospholipase A2: synthesis and evaluation as a novel bioresponsive anticancer conjugate. Biomacromolecules. 2009;10:1358–1364.
   PubMed Web of Science ®Google Scholar
• Ghomashchi F, Yu BZ, Berg O, et al. Interfacial catalysis by phospholipase A2: substrate specificity in vesicles. Biochemistry. 1991;30:7318–7329.
   PubMed Web of Science ®Google Scholar
• Carter G, White P, Fernie M, et al. Enhanced antitumour effect of liposomal daunorubicin using antibody–phospholipase C conjugates or fusion protein. Int J Oncol. 1998;13:819–825.
   PubMed Web of Science ®Google Scholar
• Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 2002;68–69:3–58.
   PubMed Web of Science ®Google Scholar
• Ferguson EL, Richardson SC, Duncan R. Studies on the mechanism of action of dextrin-phospholipase A2 and its suitability for use in combination therapy. Mol Pharm. 2010;7:510–521.
   PubMed Web of Science ®Google Scholar
• Kurioka S, Matsuda M. Phospholipase C assay using p-nitrophenylphosphoryl–choline together with sorbitol and its application to studying the metal and detergent requirement of the enzyme. Anal Biochem. 1976;75:281–289.
   PubMed Web of Science ®Google Scholar
• Sgouras D, Duncan R. Methods for the evaluation of biocompatibility of soluble synthetic polymers which have potential for biomedical use: 1 – use of the tetrazolium-based colorimetric assay (MTT) as a preliminary screen for evaluation of in vitro cytotoxicity. J Mater Sci: Mater Med. 1990;1:61–68.
   Web of Science ®Google Scholar
• Valeriote F, Lin H. Synergistic interaction of anticancer agents: a cellular perspective. Cancer Chemother Rep. 1975;59:895–900.
   PubMedGoogle Scholar
• Schellmann N, Deckert PM, Bachran D, et al. Targeted enzyme prodrug therapies. Mini Rev Med Chem. 2010;10:887–904.
   PubMed Web of Science ®Google Scholar
• Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer. 2006;6:688–701.
   PubMed Web of Science ®Google Scholar
• Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 1986;46:6387–6392.
   PubMed Web of Science ®Google Scholar
• Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomed. 2012;7:49–60.
   PubMed Web of Science ®Google Scholar
• Ruiz-Arguello MB, Goni FM, Alonso A. Phospholipase C hydrolysis of phospholipids in bilayers of mixed lipid compositions. Biochemistry. 1998;37:11621–11628.
   PubMed Web of Science ®Google Scholar
• Eaton JT, Naylor CE, Howells AM, et al. Crystal structure of the C. perfringens alpha-toxin with the active site closed by a flexible loop region. J Mol Biol. 2002;319:275–281.
   PubMed Web of Science ®Google Scholar
• Hardwicke J, Moseley R, Stephens P, et al. Bioresponsive dextrin–rhEGF conjugates: in vitro evaluation in models relevant to its proposed use as a treatment for chronic wounds. Mol Pharm. 2010;7:699–707.
   PubMed Web of Science ®Google Scholar
• Hardwicke J, Ferguson EL, Moseley R, et al. Dextrin–rhEGF conjugates as bioresponsive nanomedicines for wound repair. J Control Release. 2008;130:275–283.
   PubMed Web of Science ®Google Scholar
• Ferguson EL, De Luca E, Heenan RK, et al. Time-resolved small-angle neutron scattering as a tool for studying controlled release from liposomes using polymer–enzyme conjugates. Macromol Rapid Commun. 2010;31:1685–1690.
   PubMed Web of Science ®Google Scholar
• Lehtonen JY, Kinnunen PK. Phospholipase A2 as a mechanosensor. Biophys J. 1995;68:1888–1894.
   PubMed Web of Science ®Google Scholar
• Weitzel JN, Pooler PA, Mohammed R, et al. A unique case of breast carcinoma producing pancreatic-type isoamylase. Gastroenterology. 1988;94:519–520.
   PubMed Web of Science ®Google Scholar
• Inaji H, Koyama H, Higashiyama M, et al. Immunohistochemical, ultrastructural and biochemical studies of an amylase-producing breast carcinoma. Vichows Arch A Pathol Anat. 1991;419:29–33.
   PubMedGoogle Scholar
• Zamboni WC. Liposomal, nanoparticle, and conjugated formulations of anticancer agents. Clin Cancer Res. 2005;11:8230–8234.
   PubMed Web of Science ®Google Scholar
• Zamboni WC. Concept and clinical evaluation of carrier-mediated anticancer agents. Oncologist. 2008;13:248–260.
   PubMed Web of Science ®Google Scholar